Zyus Life Sciences Corp. is a Canadian life sciences company specializing in the development and commercialization of innovative cannabinoid-based pharmaceutical drug candidates. Its primary focus is on creating non-opioid therapies for pain management, striving to redefine the standard of care and improve patients' lives. Operating in the healthcare sector, Zyus offers cannabinoid oils, softgel capsules, and topical creams both domestically and internationally, contributing to the evolving landscape of medical cannabis and phyto-therapeutics. The company is dedicated to rigorous scientific exploration and regulatory approval processes, with the goal of gaining global recognition in the medical market. By fostering collaborations and partnerships, Zyus aims to deliver transformative healthcare solutions.